Literature DB >> 32645441

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinoma.

Deniz Balci1, Yoshihiro Sakamoto2, Jun Li3, Fabrizio Di Benedetto4, Elvan Onur Kirimker5, Henrik Petrowsky6.   

Abstract

Perihilar cholangiocarcinoma (PHCC) has been a great challenge for surgeons, requiring advanced skills and expertise and was often associated with high morbidity and mortality. Resectability rates are up to 75% even in experienced centers. In patients with PHCC, radical liver and bile duct resection aiming R0 surgical margins offers the best long-term survival. Therefore, extensive resections with low FLR are commonly needed and PVE is offered to induce remnant liver hypertrophy for a long period. Associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) is considered a promising approach inducing rapid remnant hypertrophy to prevent dropouts due to complications or tumor progression and increase resectability. Although poor results were reported initially, refinements in technique and risk adjustment of patient selection improved outcomes. The procedure is still under debate for the indication of PHCC. This article reviews the current literature on ALPPS in treatment of perihilar and intrahepatic cholangiocarcinoma.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  ALPPS; Intrahepatic cholangiocarcinoma; Perihilar cholangiocarcinoma; Portal vein embolization

Mesh:

Year:  2020        PMID: 32645441     DOI: 10.1016/j.ijsu.2020.06.045

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

Review 1.  Surgical Therapy for Perihilar Cholangiocarcinoma: State of the Art.

Authors:  Lynn E Nooijen; Rutger-Jan Swijnenburg; Heinz-Josef Klümpen; Joanne Verheij; Geert Kazemier; Thomas M van Gulik; Joris I Erdmann
Journal:  Visc Med       Date:  2021-01-07

2.  MMP2/9 downregulation is responsible for hepatic function recovery in cirrhotic rats following associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Yugang Qin; Chonghui Li; Xinlan Ge; Qiang Zhang; Xiaojun Wei; Rong Liu
Journal:  Ann Transl Med       Date:  2022-04

Review 3.  Moving forward in the treatment of cholangiocarcinoma.

Authors:  Tommaso M Manzia; Alessandro Parente; Ilaria Lenci; Bruno Sensi; Martina Milana; Carlo Gazia; Alessandro Signorello; Roberta Angelico; Giuseppe Grassi; Giuseppe Tisone; Leonardo Baiocchi
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

4.  Therapeutic Effect of Regional Chemotherapy in Diffuse Metastatic Cholangiocarcinoma.

Authors:  Yogesh Vashist; Kornelia Aigner; Sabine Gailhofer; Karl R Aigner
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

5.  Perihilar-cholangiocarcinoma: what really matters?

Authors:  Fabrizio Di Benedetto; Paolo Magistri; Stefano Di Sandro
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

6.  Liver transplantation and hepatobiliary surgery in 2020.

Authors:  Burcin Ekser; Karim J Halazun; Henrik Petrowsky; Deniz Balci
Journal:  Int J Surg       Date:  2020-07-19       Impact factor: 13.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.